Metastatic malignant melanoma in bone marrow with occult primary site - A case report with review of literature

Diagnostic Pathology

Volumn 2, Issue 1, 2007, Pages

  Jain, Deepali ^a   Singh, Tejindar ^a   Kumar, Naresh ^a   Daga, Mradul K ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37249078831     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-2-38     Document Type: Article

References (34)

1. Rigel DS, Friedman RJ, Kopf AW: The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996, 34:839-847.
2. de la Monte SM, Moore GW, Hutchins GM: Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 1983, 43(7):3427-33.
3. Savage RA, Lucas FV, Hoffman GC: Melanoma in marrow aspirates. Am J Clin Pathol 1983, 79:268-269.
4. Anbari KK, Schlichter LM, Bucky LP, Mick R, Synnestvedt M, Guerry D, Hamilton R, Halpern AC: Melanoma of unknown primary site: presentation, treatment, and prognosis - a single institution study. University of Pennsylvania Pigmented Lesion Study Group. Cancer 79(9): 1816-21. 1997 May I;
5. Baab GH, McBride CM: Malignant melanoma: the patient with an unknown site of primary origin. Arch Surg 1975, 110(8):896-900.
6. Chang P, Knapper WH: Metastatic melanoma of unknown primary. Cancer 49(6):1106-11. 1982 Mar 15;
7. Brown D, Boniuk M, Font RL: Diffuse malignant melanoma of iris with metastases. Surv Ophthalmol 1990, 34(5):357-64.
8. Tuncer I, Paydaş, S, Coşar EF, Ersöz C: Metastatic malignant melanoma in bone marrow: importance of aspiration cytology. Turkish Journal of Cancer 1994, 24:168-170.
9. Bhagwati N, Seno R, Dutcher JP, Oleksowicz L: Fulminant metastatic melanoma complicated by a microangiopathic hemolytic anemia. Hematopathol Mol Hematol 1998, 11(2): 101-8.
10. Batsis JA, Barry MJ: Metastatic malignant melanoma presenting with hypercalcaemia and bone marrow involvement. J Eur Acad Dermatol Venereol 2006, 20(4):432-4.
11. Stewart WR, Gelberman RH, Harrelson JM, Seigler HF: Skeletal metastases of melanoma. J Bone Joint Surg Am 1978, 60:645.
12. Battle JD, Stasney J: Malignant melanoma cells in the bone marrow. Arch Path 1941, 31:631-633.
13. Rubinstein MA: Aspiration of bone marrow from the iliac crest. JAMA 1948, 137:1281-1285.
14. Jonsson U, Rundles RW: Tumor metastases in bone marrow. Blood 1951, 6:16-25.
15. Durkee WR, Wilson SJ: Bone marrow biopsy as an aid in the diagnosis of metastatic malignancy. J Kans Med Soc 1951, 52:361-6.
16. Franklin JW, Zavala DC, Radcliffe CE: The detection of malignant melanoma by bone marrow aspiration; a report of two cases. Blood 1952, 7:934-41.
17. Motulsky AG, Rohn RJ: The bone marrow in metastatic malignant melanoma. J Lab Clin Med 1953, 41:526-33.
18. Gallivan MVE, Lokich JJ: Carcinocythemia (carcinoma cell leukemia). Cancer 1984, 53:1100-2.
19. Basile M, Moskowitz B, Harris J, Blumberg N, Bennett JM: Malignant melanoma: primary presentation in bone marrow and lymph node. Med Pediatr Oncol 1992, 20(1):75-7.
20. Villarrubia J, de Misa RF, Escribano L, Bellas C, Velasco JL: Amelanotic bone marrow infiltration secondary to pigmented malignant melanoma. J Dermatol 1995, 22:620-2.
21. Trefzer U, Schlegel C, Sterry W, SpÃnth-Schwalbe E, Possinger K, Denken C: Fulminant intravascular disseminating malignant melanoma mimicking acute leukemia. Blood 1999, 94:1483-4.
22. Invernizzi R, Pecci A: The irreplaceable image: A case of metastatic malignant melanoma with bone marrow involvement. Haematologica 2001, 86:447.
23. Chim CS, Trendell Smith NJ: Primary malignant ocular melanoma: a bone marrow diagnosis. Br J Haematol 2001, 112:2.
24. Basu D, Bhade BA, Ghotekar LH, Mathew T, Dutta TK: Malignant melanoma metastatic to bone marrow. Indian J Pathol Microbiol 2002, 45(1): 107-9.
25. Schadendorf D, Dorn-Beineke A, Borelli S, Riethmuller G, Pantel K: Limitations of the immunocytochemical detection of isolated tumor cells in frozen samples of bone marrow obtained from melanoma patients. Exp Dermatol 2003, 12:165-71.
26. de Wolff JF, Planken EV, den Ottolander GJ: Extreme leucocytosis and splenomegaly in metastasised melanoma. Neth J Med 2004, 62(5): 164-7.
27. Spiller SE, Hawkins DS, Finn LS, Sze RW, Sybert V: Metastatic malignant melanoma presenting as pancytopenia in a three-year-old boy. Pediatr Blood Cancer 2005, 45(1):60-3.
28. Uesawa M, Sato K, Ozaki K, Nagai T, Muroi K, Ozawa K: Bone marrow metastasis of malignant melanoma. Intern Med 2006, 45:341.
29. Wong KF: Metastatic melanoma. Br J Haematol 2006, 134(6):554.
30. White JD, MacPherson IR, Evans TR: Auto-immune neutropenia occurring in association with malignant melanoma. Oncol Rep 2003, 10(1):249-51.
31. Balch CM, Soong S-J, Gershenwald JE, et al.: Prognostic factors analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001, 19:3622-3634.
32. Smith JL Jr, Stehlin JS Jr: Spontaneous regression of primary malignant melanomas with regional metastases. Cancer 1965, 18(11):1399-415.
33. Yaziji H, Gown AM: Immunohistochemical markers of melanocyte tumors. Int J Surg Pathol 2003, 11 (I):11 -5.
34. Bacchi CE, Bonetti F, Pea M, Martignoni G, Gown AM: HMB-45: a review. Appl Immunohistochem 1996, 4:73-85.